8-K: Alignment Healthcare Reports Strong 31% Membership Growth

Alignment Healthcare announced robust 31% year-over-year membership growth and reaffirmed its 2025 financial guidance, projecting strong 2026 profitability.

Summary

• Reported approximately 275,300 Health Plan Members as of January 1, 2026, representing 31% year-over-year growth when compared with Health Plan Membership as of January 1, 2025.
• Projected year-end 2026 Health Plan Membership to be between 290,000 and 296,000, indicating 24% to 27% growth relative to the midpoint of the latest year-end 2025 membership guidance.
• Expects consensus adjusted EBITDA of approximately $145 million in 2026 to be within its full-year 2026 guidance range.
• Reaffirmed full-year 2025 guidance ranges on health plan membership (232,500-234,500), revenue ($3,931M-$3,946M), adjusted gross profit ($474M-$483M), and adjusted EBITDA ($90M-$98M).
• The company has achieved a compounded annual membership growth rate of approximately 30% since its IPO in 2021.
• 100% of members are enrolled in plans rated 4 stars or higher for the second consecutive year.

Sentiment

Score: 9

Explanation: The filing presents a highly positive outlook, driven by exceptional membership growth (31% year-over-year), strong future growth projections, and a reaffirmation of 2025 financial guidance. The company's consistent high Star Ratings and effective cost management further underscore its strong competitive position and operational excellence in the Medicare Advantage market.

Positives

• Achieved significant year-over-year Health Plan Member growth of 31% to 275,300 as of January 1, 2026.
• Projected strong Health Plan Member growth for year-end 2026, ranging from 24% to 27% (290,000 to 296,000 members).
• Expects 2026 adjusted EBITDA to be approximately $145 million, within its guidance range, indicating strong future profitability.
• Reaffirmed full-year 2025 guidance across all key metrics (membership, revenue, adjusted gross profit, adjusted EBITDA), demonstrating consistency.
• Maintained a high quality rating, with 100% of members enrolled in plans rated 4 stars or higher for the second consecutive year.
• Demonstrated strong member retention with a 19% improvement in voluntary disenrollment from 2025 to 2026 (7.9% to 6.4%).
• Experienced robust net Medicare Advantage enrollment growth across geographies, with California up 23% YoY (+41,500 members) and Ex-California up 84% YoY (+23,800 members).

Risks

• Ability to attract new members and enter new markets, including the need for certain governmental approvals.
• Ability to maintain a high rating for its plans on the Five Star Quality Rating System.
• Ability to develop and maintain satisfactory relationships with care providers that service its members.
• Risks associated with being a government contractor, including potential federal reductions in Medicare Advantage funding.
• Changes in laws and regulations applicable to its business model.
• Risks related to its indebtedness, including the potential for rising interest rates.
• Changes in market or industry conditions and receptivity to its technology and services.
• Results of litigation or a security incident.
• Impact of shortages of qualified personnel and related increases in its labor costs.

Future Outlook

The company anticipates continued strong growth in 2026, projecting year-end Health Plan Membership between 290,000 and 296,000 and expecting consensus adjusted EBITDA of approximately $145 million. Full 2026 guidance will be provided during the fourth-quarter 2025 earnings call. The company plans aggressive investments in scalability, replicability, new market infrastructure, AI deployment, clinical innovation, and sales and branding, with an aim to launch new markets in 2027, funded by internally generated cash flows.

Management Comments

• "Alignment Healthcare continues to set the bar high for Medicare Advantage done right. As we mark five years as a public company, we are proving strong business performance comes from delivering on our promise to seniors: better care, better outcomes and lower costs. The strength of our model is driving industry-leading performance in MA today and positions us for scalable, repeatable growth." John Kao, founder and CEO, Alignment Healthcare.

Industry Context

Alignment Healthcare operates in the growing Medicare Advantage (MA) market, which is projected to expand significantly over the next decade. The company's "care-centered model" and focus on clinical excellence, risk management, and AI-powered data analytics position it to defy industry trends. While peers averaged 1% annual membership growth and increased Medical Benefits Ratio (MBR) by 160 basis points from 2024 to 3Q 2025, Alignment consistently grew above 20% and managed medical costs effectively, moderating or lowering its MBR. The company's 100% enrollment in 4-star or higher plans also significantly outperforms the industry average of 65%.

Comparison to Industry Standards

• Alignment Healthcare achieved 31% year-over-year membership growth as of January 1, 2026, significantly outperforming the industry average of 1% annual membership growth observed among peers from 2024 to 3Q 2025.
• The company has maintained 100% of its members in plans rated 4 stars or higher for the second consecutive year, which is substantially above the industry average of 65% for plans rated 4 stars or greater.
• Alignment's ability to manage medical costs effectively, moderating or lowering its Medical Benefits Ratio (MBR) while growing rapidly, contrasts with faster-growing health plans in the industry that generally experienced greater increases in MBR (peers averaged a 160bps annual MBR increase from 2024 to 3Q 2025).

Stakeholder Impact

• Shareholders: Positive impact due to strong membership growth, reaffirmed financial guidance, and positive future profitability outlook, suggesting potential for increased shareholder value.
• Members: Positive impact from the company's commitment to high-quality care, evidenced by 100% of members in 4-star or higher rated plans, and enhanced benefits.
• Employees: Potential for growth and expansion of teams, particularly in AI engineering, data science, and clinical roles, as the company invests in scalability and innovation.
• Care Providers: Continued partnership opportunities and potential for improved patient economics through shared surplus gainshares, as the company aims to develop and maintain satisfactory relationships.
• Regulatory Authorities (CMS): Positive relationship due to the company's high Star Ratings and alignment with CMS's triple aim of better care, better health, and lower costs.

Next Steps

• Senior management team to meet with investors and analysts at an industry conference and various other meetings on January 12-15, 2026.
• Company's presentation at the industry conference on January 14, 2026, is expected to be webcast, with a replay available on the Investor Relations website.
• Full-year 2026 guidance will be provided at the fourth-quarter 2025 earnings call.
• Aggressively investing in scalability and replicability, including upgrading people, processes, and technology.
• Using internally generated cash flows to fund organic new market expansions and reinvestments in the business.
• Continued investments in new market infrastructure, expansion of business development pipeline, escalating marketing campaigns, workflow process automation, and transition to an event-based data architecture for AI deployment.
• Deepening bench strength by expanding AI engineers, data scientists, and clinical personnel for palliative care management and concierge case management.
• Investing in provider operations and deployment of new clinical programs.
• Launch new markets in 2027.

Key Dates

Recommendation

The filing demonstrates exceptional operational performance and a robust growth trajectory for Alignment Healthcare. The reported 31% year-over-year membership growth, coupled with a strong 2026 outlook for membership (24-27% growth) and adjusted EBITDA ($145 million), significantly outperforms industry averages. The consistent achievement of 100% 4-star or higher rated plans underscores a high-quality, differentiated care model that drives both member satisfaction and cost management. The reaffirmation of 2025 guidance provides financial stability, and strategic investments in scalability, AI, and new markets position the company for sustained long-term growth. These factors collectively indicate a compelling investment opportunity with strong upside potential.

Keywords

Medicare Advantage, Healthcare, Membership Growth, EBITDA, Financial Guidance, Star Ratings, Annual Enrollment Period, Health Plan, ALHC